OS Therapies, Inc. (OSTX)
1.00
+0.02
(+2.03%)
USD |
NYAM |
Nov 06, 16:00
0.9355
-0.06
(-6.45%)
After-Hours: 20:00
OS Therapies EPS Diluted (Quarterly) : -0.1966 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1966 |
| March 31, 2026 | -0.2688 |
| December 31, 2025 | -0.3627 |
| September 30, 2025 | -0.2153 |
| June 30, 2025 | -0.1806 |
| March 31, 2025 | -0.1824 |
| December 31, 2024 | -0.2378 |
| September 30, 2024 | -0.1809 |
| June 30, 2024 | -0.26 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.0591 |
| December 31, 2023 | -0.0706 |
| September 30, 2023 | -0.0961 |
| June 30, 2023 | -0.1214 |
| March 31, 2023 | -0.0745 |
| December 31, 2022 | -0.1025 |
| March 31, 2022 | -0.0553 |
| December 31, 2021 | -66.07 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.2674 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.632M |
| Total Expenses (Quarterly) | 8.632M |
| Enterprise Value | 46.15M |
| Earnings Yield | -104.3% |
| Normalized Earnings Yield | -104.34 |